Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295809
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-02-29
Brief Title:
A Study of NeoAdjuvant V940 and Pembrolizumab in Cutaneous Squamous Cell Carcinoma V940-007
Sponsor:
Organization:
Merck Sharp Dohme LLC